Robert Langreth

June 29, 2020

Gilead May Charge U.S. Government $2,340 Per Patient for COVID-19 Drug

June 17, 2019

Investors Shun Startups That Target Antibiotic-Resistant Superbugs

June 06, 2019

Congress Has Questions About Medical Bill Collector Hack

June 04, 2019

Collections Agency Data Breach Exposes 11.9 Million Patient Records

May 20, 2019

Some Blame the Price of Gilead's HIV Prevention Drug for Lack of Progress

May 01, 2019

HealthEquity Makes $2 Billion Offer for WageWorks

April 10, 2019

Senators Call for Probe of PBMs' 'Spread Pricing'

April 09, 2019

States Probe PBMs Over Pricing

February 18, 2019

Insulin Makers Face Drug Pricing Suit